Clinical trial
The Use of Low-Dose Carvedilol to Improve Hypoglycemia Awareness in Patients With Type 1 Diabetes Mellitus
NCT03538015 is registered in ClinicalTrials.gov with Owen Chan, PhD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Use of Low-Dose Carvedilol to Improve Hypoglycemia Awareness in Patients With Type 1 Diabetes Mellitus
- Lead sponsor
- Owen Chan, PhD
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- April 22, 2019
- Completion date
- August 10, 2020
- Enrollment
- 1 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hypoglycemia unawareness